Benzodiazepine use in COPD: empirical evidence from Norway

BACKGROUND: The common comorbidities associated with COPD include, among others, anxiety, depression, and insomnia, for which the typical treatment involves the use of benzodiazepines (BZD). However, these medicines should be used with extra caution among COPD patients, since treatment with traditio...

Descripción completa

Detalles Bibliográficos
Autores principales: Halvorsen, Thomas, Martinussen, Pål E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559252/
https://www.ncbi.nlm.nih.gov/pubmed/26356249
http://dx.doi.org/10.2147/COPD.S83107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559252/
https://www.ncbi.nlm.nih.gov/pubmed/26356249
http://dx.doi.org/10.2147/COPD.S83107

Ejemplares similares